Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Clinical trial NCT02931539 · COMPLETED
Trial details
- NCT number
- NCT02931539
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2020-08-17
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.